$TECH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-TECHNE Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIO-TECHNE Corp. Get notifications about new insider transactions in BIO-TECHNE Corp for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 31 2017 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Grant | A | 0.00 | 739 | 0 | 739 | 0 to 739 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 125.05 | 78,228 | 9,782,411 | 78,228 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 125.05 | 117,342 | 14,673,617 | 117,342 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 0.00 | 21,291 | 0 | 21,291 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Grant | A | 0.00 | 14,194 | 0 | 84,472 | 70.3 K to 84.5 K (+20.20 %) |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Seth Alpna | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | Seth Alpna | Grant | A | 0.00 | 739 | 0 | 739 | 0 to 739 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Grant | A | 0.00 | 739 | 0 | 3,712 | 3 K to 3.7 K (+24.86 %) | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 125.05 | 12,119 | 1,515,481 | 12,119 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 125.05 | 9,089 | 1,136,579 | 9,089 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 0.00 | 1,649 | 0 | 1,649 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Grant | A | 0.00 | 739 | 0 | 7,712 | 7 K to 7.7 K (+10.60 %) | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 125.05 | 12,670 | 1,584,384 | 12,670 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 125.05 | 9,503 | 1,188,350 | 9,503 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 0.00 | 1,724 | 0 | 1,724 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Sen. VP Protein Pla ... | Option Exercise | A | 125.05 | 14,323 | 1,791,091 | 14,323 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Sen. VP Protein Pla ... | Option Exercise | A | 125.05 | 10,742 | 1,343,287 | 10,742 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Sen. VP Protein Pla ... | Option Exercise | A | 0.00 | 1,949 | 0 | 1,949 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Option Exercise | A | 125.05 | 14,323 | 1,791,091 | 14,323 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Option Exercise | A | 125.05 | 10,742 | 1,343,287 | 10,742 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Option Exercise | A | 0.00 | 1,949 | 0 | 1,949 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 125.05 | 15,976 | 1,997,799 | 15,976 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 125.05 | 11,982 | 1,498,349 | 11,982 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 0.00 | 2,174 | 0 | 2,174 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 125.05 | 32,613 | 4,078,256 | 32,613 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 125.05 | 24,460 | 3,058,723 | 24,460 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 0.00 | 4,438 | 0 | 4,438 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Grant | A | 0.00 | 739 | 0 | 3,012 | 2.3 K to 3 K (+32.51 %) | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Nusse Roeland | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | Nusse Roeland | Grant | A | 0.00 | 739 | 0 | 4,712 | 4 K to 4.7 K (+18.60 %) | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Grant | A | 0.00 | 739 | 0 | 4,212 | 3.5 K to 4.2 K (+21.28 %) | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Grant | A | 0.00 | 739 | 0 | 8,212 | 7.5 K to 8.2 K (+9.89 %) | |
Oct 12 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 121.96 | 100 | 12,196 | 1,870 | 2 K to 1.9 K (-5.08 %) | |
Sep 12 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 120.94 | 100 | 12,094 | 1,970 | 2.1 K to 2 K (-4.83 %) | |
Sep 08 2017 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Sell | S | 121.73 | 1,059 | 128,909 | 914 | 2 K to 914 (-53.67 %) | |
Aug 15 2017 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 94.35 | 66,849 | 6,307,203 | 66,849 | |
Aug 15 2017 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 0.00 | 9,248 | 0 | 70,278 | 61 K to 70.3 K (+15.15 %) |
Jul 12 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 116.86 | 100 | 11,686 | 2,170 | 2.3 K to 2.2 K (-4.41 %) | |
Jul 11 2017 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Payment of Exercise | F | 117.68 | 312 | 36,716 | 1,355 | 1.7 K to 1.4 K (-18.72 %) |
Jun 13 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 113.62 | 100 | 11,362 | 2,270 | 2.4 K to 2.3 K (-4.22 %) | |
Jun 01 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 110.01 | 1,059 | 116,505 | 2,370 | 3.4 K to 2.4 K (-30.88 %) | |
May 31 2017 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Option Exercise | M | 66.59 | 5,000 | 332,950 | 0 | ||
May 31 2017 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Sell | S | 111.37 | 5,000 | 556,862 | 7,473 | 12.5 K to 7.5 K (-40.09 %) | |
May 31 2017 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Buy | M | 66.59 | 5,000 | 332,950 | 12,473 | 7.5 K to 12.5 K (+66.91 %) | |
May 30 2017 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Option Exercise | M | 66.59 | 5,000 | 332,950 | 0 | ||
May 30 2017 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Sell | S | 111.16 | 5,000 | 555,773 | 1,973 | 7 K to 2 K (-71.71 %) | |
May 30 2017 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Buy | M | 66.59 | 5,000 | 332,950 | 6,973 | 2 K to 7 K (+253.42 %) | |
May 12 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 110.59 | 100 | 11,059 | 3,429 | 3.5 K to 3.4 K (-2.83 %) | |
Apr 12 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 101.13 | 78 | 7,888 | 3,551 | 3.6 K to 3.6 K (-2.15 %) | |
Apr 12 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 101.23 | 22 | 2,227 | 3,529 | 3.6 K to 3.5 K (-0.62 %) | |
Mar 14 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 107.81 | 21 | 2,264 | 3,629 | 3.7 K to 3.6 K (-0.58 %) | |
Mar 14 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 107.76 | 79 | 8,513 | 3,650 | 3.7 K to 3.7 K (-2.12 %) | |
Feb 14 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 102.60 | 100 | 10,260 | 3,729 | 3.8 K to 3.7 K (-2.61 %) | |
Feb 03 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | A | 0.00 | 2,111 | 0 | 2,111 | |
Feb 03 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | A | 106.59 | 13,028 | 1,388,655 | 13,028 | |
Feb 03 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | A | 106.59 | 17,371 | 1,851,575 | 17,371 | |
Feb 03 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | M | 0.00 | 1,667 | 0 | 0 | |
Feb 03 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | D | 93.32 | 33,333 | 3,110,636 | 16,667 | |
Feb 03 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Buy | M | 0.00 | 1,667 | 0 | 1,667 | 0 to 1.7 K |
Jan 12 2017 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 103.57 | 100 | 10,357 | 3,829 | 3.9 K to 3.8 K (-2.55 %) | |
Dec 13 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Sell | S | 108.93 | 100 | 10,892 | 3,929 | 4 K to 3.9 K (-2.48 %) |
Dec 01 2016 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Sell | S | 106.73 | 1,000 | 106,733 | 1,973 | 3 K to 2 K (-33.64 %) |
Nov 18 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Sell | S | 105.75 | 100 | 10,575 | 4,029 | 4.1 K to 4 K (-2.42 %) |
Oct 31 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Option Exercise | A | 101.19 | 3,985 | 403,242 | 3,985 | |
Oct 31 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Grant | A | 0.00 | 914 | 0 | 4,129 | 3.2 K to 4.1 K (+28.43 %) |
Oct 31 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Sell | S | 104.71 | 100 | 10,471 | 3,215 | 3.3 K to 3.2 K (-3.02 %) |
Oct 31 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | A | 101.19 | 3,985 | 403,242 | 3,985 | |
Oct 31 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Grant | A | 0.00 | 914 | 0 | 6,973 | 6.1 K to 7 K (+15.08 %) |
Oct 31 2016 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Option Exercise | A | 101.19 | 3,985 | 403,242 | 3,985 | |
Oct 31 2016 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Grant | A | 0.00 | 914 | 0 | 3,473 | 2.6 K to 3.5 K (+35.72 %) |
Oct 31 2016 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Option Exercise | A | 101.19 | 3,985 | 403,242 | 3,985 | |
Oct 31 2016 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Grant | A | 0.00 | 914 | 0 | 3,973 | 3.1 K to 4 K (+29.88 %) |
Oct 31 2016 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Option Exercise | A | 101.19 | 3,985 | 403,242 | 3,985 | |
Oct 31 2016 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Grant | A | 0.00 | 914 | 0 | 2,273 | 1.4 K to 2.3 K (+67.26 %) |
Oct 31 2016 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Option Exercise | A | 101.19 | 3,985 | 403,242 | 3,985 | |
Oct 31 2016 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Grant | A | 0.00 | 914 | 0 | 2,973 | 2.1 K to 3 K (+44.39 %) |
Oct 31 2016 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Option Exercise | A | 101.19 | 3,985 | 403,242 | 3,985 | |
Oct 31 2016 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Grant | A | 0.00 | 914 | 0 | 7,473 | 6.6 K to 7.5 K (+13.94 %) |
Oct 31 2016 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Option Exercise | A | 101.19 | 3,985 | 403,242 | 3,985 | |
Oct 31 2016 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Grant | A | 0.00 | 914 | 0 | 2,973 | 2.1 K to 3 K (+44.39 %) |
Sep 23 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Sell | S | 108.91 | 100 | 10,891 | 3,315 | 3.4 K to 3.3 K (-2.93 %) |
Sep 12 2016 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Sell | S | 110.50 | 524 | 57,904 | 1,667 | 2.2 K to 1.7 K (-23.92 %) |
Sep 12 2016 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Sell | S | 109.83 | 1,700 | 186,716 | 1,359 | 3.1 K to 1.4 K (-55.57 %) |
Sep 06 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | M | 66.59 | 1,467 | 97,688 | 0 | |
Sep 06 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | M | 65.47 | 2,613 | 171,073 | 0 | |
Sep 06 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | M | 65.47 | 2,387 | 156,277 | 2,613 | |
Sep 06 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Sell | S | 107.15 | 2,613 | 279,987 | 6,059 | 8.7 K to 6.1 K (-30.13 %) |
Sep 06 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Buy | M | 65.47 | 2,613 | 171,073 | 8,672 | 6.1 K to 8.7 K (+43.13 %) |
Sep 06 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Sell | S | 107.18 | 3,854 | 413,052 | 6,059 | 9.9 K to 6.1 K (-38.88 %) |
Sep 06 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Buy | M | 66.59 | 1,467 | 97,688 | 9,913 | 8.4 K to 9.9 K (+17.37 %) |
Sep 06 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Buy | M | 65.47 | 2,387 | 156,277 | 8,446 | 6.1 K to 8.4 K (+39.40 %) |
Aug 26 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | M | 66.59 | 3,533 | 235,262 | 1,467 | |
Aug 26 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Sell | S | 107.10 | 3,533 | 378,378 | 6,059 | 9.6 K to 6.1 K (-36.83 %) |
Aug 26 2016 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Buy | M | 66.59 | 3,533 | 235,262 | 9,592 | 6.1 K to 9.6 K (+58.31 %) |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 0.00 | 1,759 | 0 | 1,759 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 106.59 | 10,857 | 1,157,248 | 10,857 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 106.59 | 14,476 | 1,542,997 | 14,476 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | A | 0.00 | 2,111 | 0 | 2,111 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | A | 106.59 | 13,028 | 1,388,655 | 13,028 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | A | 106.59 | 17,371 | 1,851,575 | 17,371 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Option Exercise | A | 0.00 | 2,111 | 0 | 2,111 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Option Exercise | A | 106.59 | 13,028 | 1,388,655 | 13,028 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Option Exercise | A | 106.59 | 17,371 | 1,851,575 | 17,371 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 0.00 | 1,759 | 0 | 1,759 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 106.59 | 10,857 | 1,157,248 | 10,857 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 106.59 | 14,476 | 1,542,997 | 14,476 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Biotech | Option Exercise | A | 0.00 | 2,287 | 0 | 2,287 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Biotech | Option Exercise | A | 106.59 | 14,114 | 1,504,411 | 14,114 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Biotech | Option Exercise | A | 106.59 | 18,819 | 2,005,917 | 18,819 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 0.00 | 4,925 | 0 | 4,925 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 106.59 | 30,400 | 3,240,336 | 30,400 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 106.59 | 40,533 | 4,320,412 | 40,533 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 0.00 | 24,979 | 0 | 24,979 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 106.59 | 154,169 | 16,432,874 | 154,169 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 106.59 | 102,779 | 10,955,214 | 102,779 | |
Aug 22 2016 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Grant | A | 0.00 | 16,653 | 0 | 61,030 | 44.4 K to 61 K (+37.53 %) |
Aug 19 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Sell | S | 113.70 | 100 | 11,370 | 3,415 | 3.5 K to 3.4 K (-2.84 %) |
Jul 21 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 111.03 | 100 | 11,103 | 3,615 | 3.7 K to 3.6 K (-2.69 %) | |
Jul 21 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 111.03 | 100 | 11,103 | 3,615 | 3.7 K to 3.6 K (-2.69 %) | |
Jul 12 2016 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Payment of Exercise | F | 115.17 | 309 | 35,588 | 2,191 | 2.5 K to 2.2 K (-12.36 %) |
Jul 06 2016 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Payment of Exercise | F | 112.24 | 277 | 31,090 | 1,946 | 2.2 K to 1.9 K (-12.46 %) |
Jul 06 2016 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Payment of Exercise | F | 112.24 | 533 | 59,824 | 3,936 | 4.5 K to 3.9 K (-11.93 %) |
Jun 16 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 112.15 | 100 | 11,215 | 3,715 | 3.8 K to 3.7 K (-2.62 %) | |
May 19 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 102.53 | 100 | 10,253 | 3,815 | 3.9 K to 3.8 K (-2.55 %) | |
May 10 2016 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Sell | S | 101.91 | 5,000 | 509,550 | 6,559 | 11.6 K to 6.6 K (-43.26 %) | |
May 09 2016 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Option Exercise | M | 56.17 | 5,000 | 280,850 | 0 | ||
May 09 2016 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Buy | M | 56.17 | 5,000 | 280,850 | 11,559 | 6.6 K to 11.6 K (+76.23 %) | |
May 09 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 100.24 | 500 | 50,120 | 3,915 | 4.4 K to 3.9 K (-11.33 %) | |
Apr 04 2016 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,666 | 0 | 1,667 | |
Apr 04 2016 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Payment of Exercise | F | 94.52 | 556 | 52,553 | 5,544 | 6.1 K to 5.5 K (-9.11 %) |
Apr 04 2016 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 0.00 | 1,666 | 0 | 6,100 | 4.4 K to 6.1 K (+37.57 %) |
Mar 18 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 92.90 | 100 | 9,290 | 4,415 | 4.5 K to 4.4 K (-2.21 %) | |
Feb 08 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Option Exercise | M | 70.35 | 5,000 | 351,750 | 0 | ||
Feb 08 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Sell | S | 83.68 | 5,000 | 418,400 | 4,515 | 9.5 K to 4.5 K (-52.55 %) | |
Feb 08 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Buy | M | 70.35 | 5,000 | 351,750 | 9,515 | 4.5 K to 9.5 K (+110.74 %) | |
Apr 22 2016 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Sell | S | 92.40 | 100 | 9,240 | 4,315 | 4.4 K to 4.3 K (-2.27 %) |
Jan 06 2016 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Option Exercise | A | 88.23 | 10,000 | 882,300 | 10,000 | |
Nov 02 2015 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Option Exercise | A | 87.34 | 4,260 | 372,068 | 4,260 | ||
Nov 02 2015 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Grant | A | 0.00 | 1,059 | 0 | 2,559 | 1.5 K to 2.6 K (+70.60 %) | |
Nov 02 2015 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Option Exercise | A | 87.34 | 4,260 | 372,068 | 4,260 | ||
Nov 02 2015 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Grant | A | 0.00 | 1,059 | 0 | 2,059 | 1,000 to 2.1 K (+105.90 %) | |
Nov 02 2015 | TECH | BIO-TECHNE Corp | Nusse Roeland | Option Exercise | A | 87.34 | 4,260 | 372,068 | 4,260 | ||
Nov 02 2015 | TECH | BIO-TECHNE Corp | Nusse Roeland | Grant | A | 0.00 | 1,059 | 0 | 3,059 | 2 K to 3.1 K (+52.95 %) | |
Nov 02 2015 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Option Exercise | A | 87.34 | 4,260 | 372,068 | 4,260 | ||
Nov 02 2015 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Grant | A | 0.00 | 1,059 | 0 | 4,515 | 3.5 K to 4.5 K (+30.64 %) |